Volume 25, Number 6—June 2019
Research
Phenotypic and Genomic Analyses of Burkholderia stabilis Clinical Contamination, Switzerland
Table 1
Reaction | Result | No. outbreak strains with result | Expected B. stabilis result† |
---|---|---|---|
Saccharose, sucrose‡ | – | 4 | – |
β-galactosidase‡ | – | 4 | – |
Maltose acidification | + | 3 | + |
Adonitol acidification | – | 4 | + |
Ornithine decarboxylase | – | 4 | + |
Lysine decarboxylase | – | 4 | + |
D-mannitol | – | 4 | + |
D-glucose | + | 4 | + |
D-cellobiose | + | 4 | + |
Malonate | – | 4 | + |
D-sorbitol | – | 4 | + |
Urease | – | 4 | + or – |
*Performed using VITEK 2.
†From (26,28).
‡Specific discriminatory test for B. stabilis.
1Current affiliation: Genetics and Genomics at Roche, Basel, Switzerland.
2Current affiliation: RWTH Aachen University Hospital, Aachen, Germany.
3Current affiliation: University of Bern, Bern, Switzerland
Page created: May 20, 2019
Page updated: May 20, 2019
Page reviewed: May 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.